NEYPPC Pharmacy - Unlicensed Manufactured Parenteral Specials
key details
| Value | £1,242,117,451 (£1,490,540,941 inc. VAT) |
|---|---|
| Status | planned |
| Category (CPV) | 33600000 |
| SME suitable | Yes |
| OCID | ocds-h6vhtk-06861e |
description
The North East and Yorkshire NHS Pharmaceutical Purchasing Consortium intends to establish a Dynamic Market for the supply of Unlicensed Manufactured Parenteral Specials and, subject to its establishment, to run a future procurement under this arrangement. This route enables flexible, efficient and sustainable sourcing by drawing on a continuously open pool of qualified suppliers.
The requirement will cover the provision of unlicensed manufactured parenteral specials, in accordance with UK regulatory standards. Suppliers will be required to hold all relevant licenses and approvals, and the necessary permissions to supply unlicensed medicines in the UK.
The Dynamic Market will enable Trusts across the region to access safe, compliant, and competitively sourced unlicensed medicines, ensuring resilient supply routes and strong assurance of product quality.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 20 Apr 2026 | Pipeline notice (UK1) | Procurement Act 2023 | 035538-2026 |
| 3 Jun 2026 | Preliminary market engagement (UK2) | Procurement Act 2023 | 052214-2026 |
more from Leeds Teaching Hospitals NHS Trust
- Beckett Wing Automatic Sliding Gate Repairs & Upgrades · £14,652 · 28 Jul 2026
- Hysteroscopes and baskets · £66,011 · 23 Jul 2026
- Bowel Screening Campaign Project · £16,700 · 23 Jul 2026
- Hydro-Constant Platform and Ladder · £11,728 · 23 Jul 2026
- Endo rotator Catheter · £30,000 · 23 Jul 2026
- Cervical Cancer Screening Campaign Project · 22 Jul 2026
- Communications Support Project · 22 Jul 2026
- Asbestos Removal Works · 10 Jul 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland) · £47,898,609
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.